[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Combination Aesthetics Market , 2012-2023

January 2018 | 214 pages | ID: C103741DA41EN
Precision Business Insights (PBI)

US$ 4,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global Combination Aesthetics Market

Combination aesthetics therapy is also called as polytherapy that is a treatment pathway uses more than one modality The practice is not new to medicine, but is a fairly new approach in aesthetic medicine. One of the example for combination aesthetics is botulinum toxin and fillers, which is more effective when administered along with other filler than administering alone. Some of the other types of combinations are Tissue tightening plus fillers, Tissue tightening plus fractional resurfacing with carbon dioxide, cellulite remodelling with tissue tightening etc. Over recent years there has been a sharp increase in combination therapies, with many aesthetics professionals recommending combination therapies to maximise results in anti-ageing and body contouring treatments.

The major factors that are augmenting the growth of the market are; increase in adoption of minimally invasive and non-invasive process, growing demand of aesthetic treatment among male, rise in aging population, growing awareness of cosmetics procedures, and availability of user-friendly aesthetic devices, among others. However, high cost of treatment, low reimbursements, and risk of device malfunctions associated mostly with implants, low focus on combination aesthetics for the dermatological conditions, stringent regulation on aesthetics procedures and increase in adoption of branded beauty and cosmetics product are major factors that hamper the growth of global combination aesthetics market.

Combination aesthetics market are segmented on the basis of treatment, application, end-user and by region.

Based on the treatment, combination aesthetics market are segmented as:
  • Botulinum Toxin- A (BTx-A)/Dermal Filler
  • Botulinum Toxin- A (BTx-A)/Laser
  • Laser/Topical Drug
  • Laser/Radiofrequency
  • Dermal filler/Topical drug
  • Others
Based on the application, combination aesthetics market are segmented as:
  • Hair Removal
  • Tattoo Removal
  • Skin Resurfacing
  • Scar Removal
  • Others
Based on the end-user, combination aesthetics market are segmented as:
  • Hospitals
  • Ambulatory Surgical Centers
  • Dermatological Clinics
Due to intense cut-throat competition, there is a constant pressure on the players in the facial rejuvenation market to introduce newer products that is still in its nascent stage and in a constant state of flux. Due to this intense competitive pressure, there is a compulsion for early introduction of products, especially peels, topical solutions, etc. In 2014, the American Society for Aesthetic Plastic Surgery stated that about 3.5Mn botulinum toxin procedures were performed in the US. In the same year International Society of Aesthetic Plastic Surgery also reported that about 4.8 Mn procedures of botulinum toxin were done globally. and in 2013, American Society for Dermatologic Surgery survey reported that 20% rise in the botulinum toxin procedures compared to 2012.There is an abundance of dermatology service providers in low-income countries such as India, Thailand, Malaysia, and Vietnam who tend to prescribe chemical peels and various creams and lotions as the best treatment options for facial rejuvenation. However, in contrast to this, in economically affluent countries such as U.S., U.K., UAE and Japan, the use of only approved Botulinum type-A neurotoxins is seen and in such countries, close to 50% procedures are done using Botulinum type-A injections. Hence, easier availability of products and affordability is set to increase the demand for combination therapy for enhanced results and is therefore set to boost the global aesthetics combination therapy market.

On the basis of region presence, combination therapies in aesthetics market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East and Africa. North America and Europe are the biggest markets for the combination therapies in aesthetics market. North America market is expected to continue to dominate over the next few years due to higher number of U.S. FDA approvals for botulinum products in the region. However, it is harder to get Health Canada approvals. Asia-Pacific market is comparatively smaller and less penetrated than other regional markets. However, it is one the fastest growing market due to rising patient awareness for various therapeutic options and increase in accessibility to these procedures. Combination treatments such wrinkle lifting plus volume restoring are gaining popularity in this region. Healthy economic growth and disposable income levels in Brunei, Cambodia, Indonesia, Laos, Malaysia, Philippines, Singapore, Thailand, and Vietnam contribute largely to increasing demand for facial injectable products.

Some of the key market players in the combination therapies in aesthetics market are Merz Pharma GmbH & Co. KGaA (Germany), Biopolymer GmbH &Co KG (Germany), Revance Therapeutics Inc. (U.S.), Mentor Worldwide LLC (U.S.), Alma Lasers (Israel), Anika Therapeutics.Inc. (U.S.), Contura International A/S (Denmark), Cynosure. Inc. (U.S.), and GaldermaS.A. (Nestle) (Switzerland)

In April 2016, Galderma and Mentor Worldwide LLC, entered into new nationwide collaboration in order to partner with the surgeons globally to elevate the patient experience across the company innovative aesthetic & corrective brands and offerings

In April 2017, Allergan plc successfully completed the acquisition of ZELTIQ® Aesthetics, Inc., to strengthen its body contouring business segment
1. EXECUTIVE SUMMARY

2. GLOBAL COMBINATION AESTHETICS MARKET INTRODUCTION

2.1. Global Combination Aesthetics Market – Taxonomy
2.2. Global Combination Aesthetics Market –Definitions
  2.2.1. Treatement Type
  2.2.2. Application

3. GLOBAL COMBINATION AESTHETICS MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Combination Aesthetics Market Dynamic Factors - Impact Analysis

4. GLOBAL COMBINATION AESTHETICS MARKET ANALYSIS, 2012 – 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis

5. GLOBAL COMBINATION AESTHETICS MARKET, BY TREATMENT TYPE, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

5.1. Botulinum Toxin- A (BTx-A)/Dermal Filler
  5.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.1.3. Market Opportunity Analysis
5.2. Botulinum Toxin- A (BTx-A)/Laser
  5.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.2.3. Market Opportunity Analysis
5.3. Laser/Topical Drug
  5.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.3.3. Market Opportunity Analysis
5.4. Laser/Radiofrequency
  5.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.4.3. Market Opportunity Analysis
5.5. Dermal filler/Topical drug
  5.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.5.3. Market Opportunity Analysis
5.6. Others
  5.6.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.6.3. Market Opportunity Analysis

6. GLOBAL COMBINATION AESTHETICS MARKET, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

6.1. Hair Removal
  6.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.1.3. Market Opportunity Analysis
6.2. Tattoo Removal
  6.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.2.3. Market Opportunity Analysis
6.3. Skin Resurfacing
  6.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.3.3. Market Opportunity Analysis
6.4. Scar Removal
  6.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.4.3. Market Opportunity Analysis
6.5. Others
  6.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.5.3. Market Opportunity Analysis

7. GLOBAL COMBINATION AESTHETICS MARKET, BY END USER, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

7.1. Hospitals
  7.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.1.3. Market Opportunity Analysis
7.2. Dermatology Clinics
  7.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.2.3. Market Opportunity Analysis
7.3. Ambulatory Surgical Centers
  7.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.3.3. Market Opportunity Analysis

8. GLOBAL COMBINATION AESTHETICS MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

8.1. North America
  8.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.1.3. Market Opportunity Analysis
8.2. Europe
  8.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
  8.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.3.3. Market Opportunity Analysis
8.4. Latin America
  8.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
  8.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.5.3. Market Opportunity Analysis
8.6. Global Combination Aesthetics Market - Opportunity Analysis Index, By Treatment Type, By End User, and Region, 2017 – 2023

9. NORTH AMERICA COMBINATION AESTHETICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

9.1. Treatment Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  9.1.1. Botulinum Toxin- A (BTx-A)/Dermal Filler
  9.1.2. Botulinum Toxin- A (BTx-A)/Laser
  9.1.3. Laser/Topical Drug
  9.1.4. Laser/Radiofrequency
  9.1.5. Dermal filler/Topical drug
  9.1.6. Others
9.2. Application Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  9.2.1. Hair Removal
  9.2.2. Tattoo Removal
  9.2.3. Skin Resurfacing
  9.2.4. Scar Removal
  9.2.5. Others
9.3. End User Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  9.3.1. Hospitals
  9.3.2. Dermatology Clinics
  9.3.3. Ambulatory Surgical Centers
9.4. Country Analysis 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  9.4.1. U.S.
  9.4.2. Canada
9.5. North America Combination Aesthetics Market - Opportunity Analysis Index, By Treatment Type, By Application, By End User, and Country, 2017 – 2023
9.6. North America Combination Aesthetics Market Dynamics – Trends

10. EUROPE COMBINATION AESTHETICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

10.1. Treatment Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  10.1.1. Botulinum Toxin- A (BTx-A)/Dermal Filler
  10.1.2. Botulinum Toxin- A (BTx-A)/Laser
  10.1.3. Laser/Topical Drug
  10.1.4. Laser/Radiofrequency
  10.1.5. Dermal filler/Topical drug
  10.1.6. Others
10.2. Application Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  10.2.1. Hair Removal
  10.2.2. Tattoo Removal
  10.2.3. Skin Resurfacing
  10.2.4. Scar Removal
  10.2.5. Others
10.3. End User Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  10.3.1. Hospitals
  10.3.2. Dermatology Clinics
  10.3.3. Ambulatory Surgical Centers
10.4. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  10.4.1. Germany
  10.4.2. UK
  10.4.3. France
  10.4.4. Spain
  10.4.5. Italy
  10.4.6. Russia
  10.4.7. Poland
  10.4.8. Rest of Europe
10.5. Europe Combination Aesthetics Market - Opportunity Analysis Index, By Treatment Type, By Application, By End User, and Country, 2017 – 2023
10.6. Europe Combination Aesthetics Market Dynamics – Trends

11. ASIA-PACIFIC COMBINATION AESTHETICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

11.1. Treatment Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  11.1.1. Botulinum Toxin- A (BTx-A)/Dermal Filler
  11.1.2. Botulinum Toxin- A (BTx-A)/Laser
  11.1.3. Laser/Topical Drug
  11.1.4. Laser/Radiofrequency
  11.1.5. Dermal filler/Topical drug
  11.1.6. Others
11.2. Application Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  11.2.1. Hair Removal
  11.2.2. Tattoo Removal
  11.2.3. Skin Resurfacing
  11.2.4. Scar Removal
  11.2.5. Others
11.3. End User Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  11.3.1. Hospitals
  11.3.2. Dermatology Clinics
  11.3.3. Ambulatory Surgical Centers
11.4. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  11.4.1. Japan
  11.4.2. China
  11.4.3. India
  11.4.4. ASEAN
  11.4.5. Australia & New Zealand
  11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Combination Aesthetics Market - Opportunity Analysis Index, By Treatment Type, By Application, By End User, and Country, 2017 – 2023
11.6. Asia-Pacific Combination Aesthetics Market Dynamics – Trends

12. LATIN AMERICA COMBINATION AESTHETICS MARKET ANALYSIS, 2012 - 2012 - 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

12.1. Treatment Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  12.1.1. Botulinum Toxin- A (BTx-A)/Dermal Filler
  12.1.2. Botulinum Toxin- A (BTx-A)/Laser
  12.1.3. Laser/Topical Drug
  12.1.4. Laser/Radiofrequency
  12.1.5. Dermal filler/Topical drug
  12.1.6. Others
12.2. Application Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  12.2.1. Hair Removal
  12.2.2. Tattoo Removal
  12.2.3. Skin Resurfacing
  12.2.4. Scar Removal
  12.2.5. Others
12.3. End User Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  12.3.1. Hospitals
  12.3.2. Dermatology Clinics
  12.3.3. Ambulatory Surgical Centers
12.4. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  12.4.1. Brazil
  12.4.2. Mexico
  12.4.3. Argentina
  12.4.4. Venezuela
  12.4.5. Rest of Latin America
12.5. Latin America Combination Aesthetics Market - Opportunity Analysis Index, By Treatment Type, By Application, By End User, and Country, 2017 – 2023
12.6. Latin America Combination Aesthetics Market Dynamics – Trends

13. MIDDLE EAST AND AFRICA COMBINATION AESTHETICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023 (REVENUE, USD MN)

13.1. Treatment Type Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  13.1.1. Botulinum Toxin- A (BTx-A)/Dermal Filler
  13.1.2. Botulinum Toxin- A (BTx-A)/Laser
  13.1.3. Laser/Topical Drug
  13.1.4. Laser/Radiofrequency
  13.1.5. Dermal filler/Topical drug
  13.1.6. Others
13.2. Application Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  13.2.1. Hair Removal
  13.2.2. Tattoo Removal
  13.2.3. Skin Resurfacing
  13.2.4. Scar Removal
  13.2.5. Others
13.3. End User Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  13.3.1. Hospitals
  13.3.2. Dermatology Clinics
  13.3.3. Ambulatory Surgical Centers
13.4. Country Analysis 2012 - 2016 and Forecast 2017 – 2023 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  13.4.1. Gulf Cooperation Council (GCC) Countries
  13.4.2. Israel
  13.4.3. South Africa
  13.4.4. Rest of MEA
13.5. MEA Combination Aesthetics Market - Opportunity Analysis Index, By Treatment Type, By End User, By Application, and Country, 2017 – 2023
13.6. MEA Combination Aesthetics Market Dynamics – Trends

14. COMPETITION LANDSCAPE

14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  14.2.1. Merz Pharma GmbH & Co. KGaA (Germany)
  14.2.2. Biopolymer GmbH &Co KG (Germany)
  14.2.3. Revance Therapeutics Inc. (U.S.)
  14.2.4. Mentor Worldwide LLC (U.S.)
  14.2.5. Alma Lasers (Israel)
  14.2.6. Anika Therapeutics.Inc. (U.S.)
  14.2.7. Contura International A/S (Denmark)
  14.2.8. Cynosure. Inc. (U.S.)
  14.2.9. GaldermaS.A. (Nestle) (Switzerland)

15. RESEARCH METHODOLOGY

16. KEY ASSUMPTIONS AND ACRONYMS


More Publications